Granulocyte  cells/mm
Granulocyte > /ul within four weeks of enrollment
Granulocyte count ? /mm^
Granulocyte count >= /mm ((within  days before starting therapy)
Granulocyte count >= /mm^ (within  days before starting therapy)
Granulocyte count </mm
Granulocyte count >= ,/mm^ (within  days of enrollment)
Granulocyte count > /mm^
PART  GROUP A INCLUSION CRITERIA: Peripheral ANC >= /mm^ (. x ^/L) without granulocyte growth factor for >=  days
PART  GROUP  INCLUSION CRITERIA: Peripheral ANC >= /mm^ (. x ^/L) without granulocyte growth factor for >=  days
Granulocyte count >= ,/mm^
Granulocyte count >= /mm^
Granulocyte count >= ,/mm
Granulocyte count >= /mm^
Granulocyte >= /ul
Granulocyte count ? /mm^ ?  weeks
Granulocyte >= ,/uL
Peripheral granulocyte count of > ,/mm^
Granulocyte count >= ,/mm^
Granulocyte > /ul
Granulocyte count of at least ,/uL
Granulocyte >= /ul
Granulocyte count >= ,/uL for lapatinib and > ,/uL for capecitabine
Granulocyte count >= /mm^ (within  days before starting therapy)
Peripheral granulocyte count of >= ,/mL
Granulocyte count >= ,/mm^
Peripheral granulocyte count of >= /mm
Granulocyte count >= /mm^ (within  days before starting therapy)
Granulocyte count >= /mm^
Granulocyte count >= /mm^
Granulocyte count >= /mm^
Granulocyte count >= ,/mm^ within  days of starting therapy
Granulocyte count >= ,/uL
Granulocyte count > /mm^
Total granulocyte count of > 
Total granulocyte count of > . x ^/L
